179 related articles for article (PubMed ID: 34075107)
21. Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms.
Horita Y; Kaira K; Kawasaki T; Mihara Y; Sakuramoto S; Yamaguchi S; Okamoto K; Ryozawa S; Kanai Y; Yasuda M; Hamaguchi T
In Vivo; 2021; 35(4):2425-2432. PubMed ID: 34182526
[TBL] [Abstract][Full Text] [Related]
22. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
Roy S; Kaur M; Agarwal C; Tecklenburg M; Sclafani RA; Agarwal R
Mol Cancer Ther; 2007 Oct; 6(10):2696-707. PubMed ID: 17938263
[TBL] [Abstract][Full Text] [Related]
23. Significance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestines.
Ohno C; Nakanishi Y; Honma T; Henmi A; Sugitani M; Kanai Y; Nemoto N
Acta Histochem Cytochem; 2009 Jun; 42(3):73-81. PubMed ID: 19617954
[TBL] [Abstract][Full Text] [Related]
24. Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.
Xu M; Sakamoto S; Matsushima J; Kimura T; Ueda T; Mizokami A; Kanai Y; Ichikawa T
J Urol; 2016 May; 195(5):1588-1597. PubMed ID: 26682754
[TBL] [Abstract][Full Text] [Related]
25. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
[TBL] [Abstract][Full Text] [Related]
26. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
[TBL] [Abstract][Full Text] [Related]
27. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
[TBL] [Abstract][Full Text] [Related]
28. Expression of amino acid transporter LAT1 and 4F2hc in the healing process after the implantation of a tooth ash and plaster of Paris mixture.
Kim SG; Ahn YC; Yoon JH; Kim HK; Park SS; Ahn SG; Endou H; Kanai Y; Park JC; Kim DK
In Vivo; 2006; 20(5):591-7. PubMed ID: 17091765
[TBL] [Abstract][Full Text] [Related]
29. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells.
Li S; Whorton AR
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1263-71. PubMed ID: 17092994
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of L type amino acid transporter 1 after spinal cord injury in rats.
Toyooka T; Nawashiro H; Shinomiya N; Yano A; Ooigawa H; Ohsumi A; Uozumi Y; Yanagawa Y; Matsuo H; Shima K
Acta Neurochir Suppl; 2008; 102():385-8. PubMed ID: 19388351
[TBL] [Abstract][Full Text] [Related]
32. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Ogata S; Matsuo H; Kanai Y; Endou H; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Kawai T
Virchows Arch; 2007 Sep; 451(3):681-90. PubMed ID: 17622555
[TBL] [Abstract][Full Text] [Related]
33. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.
Wu D; Yan R; Song S; Swansiger AK; Li Y; Prell JS; Zhou Q; Robinson CV
Nat Commun; 2024 May; 15(1):3711. PubMed ID: 38697966
[TBL] [Abstract][Full Text] [Related]
34. L-Leucine and L-isoleucine enhance growth of BBN-induced urothelial tumors in the rat bladder by modulating expression of amino acid transporters and tumorigenesis-associated genes.
Xie XL; Kakehashi A; Wei M; Yamano S; Takeshita M; Yunoki T; Wanibuchi H
Food Chem Toxicol; 2013 Sep; 59():137-44. PubMed ID: 23747718
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
36.
Kantipudi S; Harder D; Bonetti S; Fotiadis D; Jeckelmann JM
Methods Protoc; 2021 Jul; 4(3):. PubMed ID: 34449687
[TBL] [Abstract][Full Text] [Related]
37. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural immunohistochemical study of L-type amino acid transporter 1-4F2 heavy chain in tumor microvasculatures of N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) induced rat bladder carcinoma.
Kume E; Mutou T; Kansaku N; Takahashi H; Wempe MF; Ikegami M; Kanai Y; Endou H; Wakui S
Microscopy (Oxf); 2017 Jun; 66(3):198-203. PubMed ID: 28339760
[TBL] [Abstract][Full Text] [Related]
39. Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria.
Rajan DP; Kekuda R; Huang W; Wang H; Devoe LD; Leibach FH; Prasad PD; Ganapathy V
J Biol Chem; 1999 Oct; 274(41):29005-10. PubMed ID: 10506149
[TBL] [Abstract][Full Text] [Related]
40. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]